after insulin infusion into the intact dog (3). In earlier experiments it was found that insulin infusions led to a cessation of glycogen loss and an accumulation of liver glycogen composed of glucosyl units which derived from 14C-labeled plasma glucose (4).
These observations in the whole animal indicated that insulin affected the hepatic cell directly.
This conclusion was consistent with the work of others who have shown apparent hepatic effects of insulin in the isolated perfused ,organ ( 12, 16, 24, 25) , even though the latter observations were related to the metabolism of glucose, nitrogen, and fat rather than specifically of glycogen. Since glucose must be infused along with insulin in the whole animal to prevent the development of a counterinsulin reaction consequent to the induced hypoglycemia (7), it is reasonable to question whether the observed effects resulted from the action of these compounds separately or in combination. It has been suggested by DeWulf and Hers (8) that a high glucose concentration in blood might decrease the basal secretion rate of glucagon, a known insulin antagonist.
On the other hand, evidence has appeared indicating that in the isolated perfused liver the perfusate concentration of glucose alone may regulate metabolism of glycogen (6, 10) . This is a report of further studies of liver glycogen transferase and phosphorylase activity during insulin infusion which were carried out to correlate the enzymic changes with previously observed changes in liver glycogen and glucose metabolism in the whole animal. In addition, by using pancreatectomized dogs, an attempt was made to separate the effect of hyperglycemia alone from that of insulin. A possible role for 3') 5'-cyclic AMP in the development of the altered enzyme activity was investigated by determining the liver concentrations of this cyclic nucleotide during insulin infusion. Table 1 and three others, G, H, and  1, in Tables 2 and 3) general anesthesia from sodium pentobarbital was used for collection of larger liver samples through a laparotomy incision.
METHODS

Care of Animals
The pieces of liver were quickly blotted and frozen in less than 15 set after removal by immersing them either in isopentane, at -150 C or alternatively, by compressing them between aluminum blocks which had been precooled in liquid nitrogen.
Insulin (low in glucagon)l was freshly dissolved in 0.15 M sodium chloride, pH 3.0, and infused either separately (Table 1) or upon addition to an 18 % solution of glucose, pH 3.0 (Tables 3, 4) .
Hepatic glucose -12C was measured in some experiments (Table  1) by an isotope-dilution technique (4). For this, the body glucose pool was labeled to constant specific activity with trace amounts of glucose-l-l 4C2 (for instance 4.3 PC as an intravenous priming injection and 0.04 &min infused into a saphenous vein throughout the 5-to 6-hr experiment).
After 60 min had elapsed to allow for mixing, samples of jugular venous blood were withdrawn into heparinized syringes at 15-to 30-min intervals through an indwelling polyethylene catheter.
The plasma was immediately separated by centrifugation and frozen. The glucose concentration in a 1 : 15 diluted protein-free filtrate of the plasma (27) was determined with glucose oxidase. The amount of 14C specifically located in the carbon-l of the plasma glucose was determined by measuring the 14C02 evolved during fermentation of the sample using Leuconostoc mesenteroides, strain 39, according to the method described in the APPENDIX. During the 2nd and 3rd hr of the isotope infusion, control samples of blood and liver were collected and the insulin (0.04 to 0.20 U/kg per hour) was administered, first as a rapid injection (2.0 ml in 2 min) and then as a slower constant infusion (0.135 ml/min).
In order to limit the degree of hypoglycemia brought about by the insulin, a continuous glucose infusion (400-600 mg/kg per hr) was started about 15 min after the start of the insulin infusion. Glucose-l -14C was added to the glucose infusion so that the specific radioactivity of the infusion approximated that of the plasma glucose. In other experiments (Tables 3, 4) the glucose concentration in whole blood, after treatment with oxalate and sodium fluoride, was determined by an automated ferricyanide method (Technicon).
Hepatic glucose-6-P and UDPglucose concentrations were determined microfluorometrically, using glucose-6-P 
RESULTS
Studies in Intact Dogs
It was reported earlier (3) that administration of insulin in relatively high doses (2.0 p/kg per hr) resulted in both transferase activation and phosphorylase inactivation. To determine whether the two enzyme systems were equally responsive to this hormone, the activities of these enzymes were determined after infusion of the lowest dose of insulin that would decrease hepatic glucose output (4). Table 1  summarizes the results from six dogs in which seven experiments with a low rate of insulin infusion (0.4 to 0.20 U/kg per hour) resulted in a 40-60 % decrease in hepatic glucose output, similar to that reported elsewhere (4). In these experiments a 3-to lo-fold increase in transferase I activity (from 2 & 1% to 9 =t 2 % I/total) was associated with a 25% decrease in phosphorylase activity (from 7.6 rfi 0.5 to 5.6 + 0.7 pmoles inorganic P liberated per hour per milligram protein). For comparison, in four experiments using three of these same dogs (reported in part previously (3) a higher rate of insulin infusion ( 1.3-2.7 U/kg per hr) resulted in a greater increase in transferase I (to 20 =t 6 %) and a greater decrease in phosphorylase (to 2.5 -+: 0.3 pmoles P/hr per mg). Measurements of 3' ,5'-cyclic AMP concentration in these same liver samples showed no significant change when greater insulin effects were produced with the lo-fold greater rate of insulin infusion. Glucose (0.4-l .5 g/kg per hr) was infused along with the insulin, since it is known that severe hypoglycemia will obliterate at least some effects of insulin upon liver glucose metabolism (7). The average plasma glucose concentration during the infusions was the same as in the control period ( 100 mg/ 100 ml). In three experiments, in which hypoglycemia (45-55 % of control value) was observed, slightly less change in enzyme activity was seen than in five experiments in which the plasma glucose concentration was elevated an average of 30 mg/ 100 ml above the control value. Figure 1 shows in detail one of the three experiments in which a glucose infusion (0.6 g/kg per hr), started 17 min after the beginning of a low-rate of insulin infusion (0.20 U/kg per hr), kept the plasma glucose at essentially the control level. There was a progressive increase in the I form of transferase during the 90-min infusion period (from 2 to 16 %). The small increase in the activity of transferase measured in the presence of glucose-62 (i.e., total) under the assay conditions employed may be explained, at least in part, by the previously described changes in the kinetic characteristics of the enzyme (3) that accompany the conversion of the D to the I form. A decrease in phosphorylase activity was more clearly seen when the assay was done without added 5'-AMP (1.5 mM) in the test mixture because it is known that this nucleotide stimulates both the active and the inactive form of liver phosphorylase an equal amount (33). Th e d ecrease in UDPglucose concentration (from 0.3 1 to 0.16 mmoles/kg) along with transferase activation has been shown to be associated with increased glycogen synthesis ( 15, 18) . The glucose-6-P levels (0.24 mmoles/kg) were unchanged or increased during insulin infusion. When the insulin-induced enzyme activity changes were reversed, as when insulin was stopped and a glucagon infusion was started, glucose-62 concentration increased to 1.05 mmoles/kg.
It was concluded that the systems for activating transferase and for inactivating phosphorylase were probably equally sensitive to insulin.
In order to determine the extent to which these two enzyme changes, brought on by the administration of insulin (Table 1) correlated with observed rates of glycogen breakdown and synthesis in vivo, these parameters have been calculated from the observed enzyme activities. Table 2 is a summary of such catalytic capacities and compares them to glucose output measurements made in these experiments and in 11 previous experiments in which changes in liver glycogen content and in glycogen labeling with plasma glucose-14C were measured directly (4). The potential of liver phosphorylase to catalyze glycogen breakdown (9,120 pmoles/hr per 30 g liver) was 9 times greater than the observed rate of glucoseJ2C output from the liver ( 1,066 pmoles/hr per kg body wt). The rate of glucoseJ2C loss from glycogen (870 pmoles/hr per 30 g liver) nearly equaled the rate of hepatic glucose-12C output ( 1,000 pmoles/hr per kg body wt). The smaller amounts of infused insulin (0.04-0.20 U/hr per kg) reduced glucose output (to 55 % of the control) and also phosphorylase activity (to 73 % of the control), whereas with 10 times this amount of insulin, phosphorylase activity decreased further (to 33 % of the control).
Transferase I activity increased severalfold after about 70 min of the infusion with lower insulin dose, as did the incorporation of plasma glucoseJ4C into glycogen (from 24 and 6 to 118 and 116 pmoles/hr per 30 g liver, respectively). After a longer period (about 137 min) of the infusion with lower insulin dose, the rate of glucose-14C incorporation into glycogen had increased further (to 495 ,umoles/hr), but with the higher insulin dose such a greater increase in transferase I activity (to 275 pmoles/hr per 30 g liver) was observed more quickly (after about 15 min).
Glucose alone ( 1.5 g/kg per hr), infused for 30 min ( Fig.  2A and Table 3 Infusion of glucose (0.6 g/kg per hr) was started 17 rnin after insulin.
After insulin and glucose infusions were stopped glucagon was infused (0.010 mg/kg per hr). namely that infused glucose promoted these reciprocal changes in enzyme activity indirectly by promoting a decrease in basal glucagon secretion, since the glucagon-secreting alpha cells as well as the insulinsecreting beta cells would be absent in the pancreatectomized animal.
Studies in Pancreatectomized Dogs
Dogs con trolled by daily maintenance insulin injections. The effects of insulin administration in four pancreatectomized dogs, given sufficient daily insulin to control excessive glycosuria, were compared with those observed in three intact dogs (Table 3) . During the control period ( 18 hr after the last meal and the last insulin injection) transferase I activity was low (less than 8 % of total), but phosphorylase activity, which was much more variable, was about twice that found in the intact dogs. Infusion of glucose alone (1.5 g/kg per hr) for 30 min promoted little or no change in transferase I activity in three pancreatectomized dogs, compared to the 15-fold increase in the one intact dog (B-5) tested in this series of experiments (Fig. 2) . Inclusion of insulin (3.2 U/kg per hr) in the subsequent 30 min of glucose infusion (2.5 g/kg per hr) produced a 7-to lo-fold activation of transferase in these experiments.
A comparable degree of transferase activation was seen in both the intact and the pancreatectomized dogs when the same amount of insulin was included in the first 30 min of a glucose infusion (experiments A-6, G, and 1). Whole-blood glucose level in the pancreatectomized dogs was increased from about 250 mg/ 100 ml in the control period to about 450 mg/ 100 ml during the glucose infusion and to about 630 mg/ 100 ml during the infusion of insulin with glucose. Phosphorylase activity during the infusion of glucose alone was variable but somewhat lower than in the control period and was decreased further when insulin was added to the glucose infusion. No explanation can be offered either for the variability in phosphorylase activity, which was especially apparent in the control periods, or for the increase with insulin in one dog (dog G), that had abdominal surgery.3 The concentration of 3', 5'-cyclic AMP in the livers of the six animals, comparably tested (Table 3 , except experiment A-S), was decreased from 1.6 1 + .19 pmoles/kg in the control (and glucose infusion) periods to 1.36 + 25 pmoles/kg during the infusion of insulin (3.2 U/kg per hr) with glucose. (Table 3 , experiment A-5), no decrease in CAMP concentration was observed. A 30-fold rise in CAMP concentration was observed when glucagon ( lo-20 pg/kg) was injected after stopping the insulin infusion (Table  3 , experiments 5 (C-l) and 6 (C-l)), w h ereas, if a comparable insulin infusion was continued in two other experiments (Table  1) , only a two-to threefold rise was observed (namely, from 1.27 and 1.16 to 2.27 and 3.20 pmoles/kg, respectively). Diabetic dogs after withdrawal of maintenance insulin. Three pancreatectomized dogs were allowed to become insulin deficient, with high glycosuria (more than 60 g/day), by withholding daily insulin injections for 2 or 4 days (Table 4) . A comparable infusion of insulin (3.2 U/kg per hr) plus glucose (2.5 g/kg per hr) promoted an increase in activity of transferase (from 4 =t 1% I/total in control periods to 12 & 3 % within 30 min), which was less than the increase (3 % to 45 %) observed with insulin administration in the controlled state (Table 3 ). The phosphorylase activity in the control periods was too variable to provide for meaningful interpretation but could be shown to decrease more than half in two of the three cases. Whole-blood glucose concentration was elevated (440 mg/ 100 ml) and remained high during the infusion (640 mg/ 100 ml).
Because the hepatic concentration of CAMP has been found to be elevated in the diabetic state induced with alloxan in the rat ( 17), it seemed likely that the apparent insulin resistance of the diabetic dog may have been the result of a similar phenomenon.
However, this possibility was not borne out by the finding that the concentrations of CAMP observed in liver were no higher in the diabetic ( 1.59 & .47 pmoles/kg) than in the controlled pancreatectomized dog (or in the intact dog) (1.87 r+ .28 and 1.63 + .12 pmoles/kg, respectively). This relationship is more clearly shown in the case of dogs 5 and 6 where the two conditions were observed in the same animal.
DISCUSSION
The results of these experiments indicate that activation of liver glycogen transferase when the intact dog is infused with insulin and supplemental glucose (3) is promoted by the insulin itself, rather than by the glucose which was intended to prevent the development of hypoglycemia. This effect of the hormone was shown under two conditions which greatly reduce the possibility that a decrease in basal glucagon secretion, promoted by the infused glucose, was more important than the infused insulin in activating transferase. In one condition, the amount of glucose infused with the insulin was not sufficient to produce hyperglycemia in 6 of the 11 studies in intact animals ( Fig. 1 and Table 1 ). Thus, in these experiments, it would not seem reasonable to expect that a decrease in glucagon secretion occurred.
In the second condition extra insulin was capable of activating transferase under circumstances when hyperglycemia alone was ineffective, namely, when both the insulin-secreting and the glucagon-secreting cells were removed by pancreatectomy ( Fig. 2B and Table 3 ). This insulin-controlled pancreatectomized animal was not severely insulin deficient, since near-normal blood glucose levels were maintained by the daily insulin injections before the daily hormone administration was terminated. However, there was a chronic deficiency of pancreatic glucagon.
BISHOP, GOLDBERG, AND LARNER
In these experiments the activation of glycogen transferase was apparently mediated more directly through the action of insulin itself than through a pathway which would involve an influence of glucagon via 3', 5'-CAMP on transferase I kinase. Nevertheless, it is conceivable that in the intact animal ( Fig. 2A ) a decrease in basal glucagon secretion could potentiate, but not necessarily initiate, the activation of transferase, which was shown here to be promoted by extra circulating insulin, whether secreted or infused. Similar demonstrations of an insulin requirement for transferase activation following hydrocortisone administration to adrenalectomized rats ( 18) and following puromycin administration to intact tadpoles (5) have been reported.
In the light of these experiments three possible mechanisms by which insulin may act on liver directly to promote transferase activation could be considered.
Decrease in Basal Transferase I Kinase Activity Secondary to a Decrease in Cellular 3' , ~/-CAMP Concentration
That insulin promotes reciprocal changes in the activity of transferase and phosphorylase in liver makes attractive the hypothesis that both enzyme changes are promoted by a common mechanism, such as a lowering of liver concentrations of 3', 5'-cyclic AMP. Cyclic AMP is a known stimulator in vitro of ki .nases in liver and in muscle which promote (indirectly) the activation of phosphorylase and inactivation of transferase (i.e., a decrease in transferase activity in the 1 form).
The implication of this hypothesis is that insulin affects the adenyl cyclase and/or phosphodiesterase which regulates the tissue concentration of CAMP. The total experience reported here ( 14 experiments) indicated no significant change in CAMP concentrations when transferase was activated to varying degrees by amounts of insulin extending over more than a 20-fold range of concentrations in the infusion ( 1.39 + .36 and 1.3 1 + .30 ,umoles/kg, respectively). However, in the six experiments with the largest insulin infusion (3.2 p/kg per hr) with glucose, a small progressive decrease in liver CAMP concentration was seen which was of a similar degree to that observed by Exton and Park ( 17) following perfusion of a normal rat liver with insulin. These investigators consider such a small decrease to be physiologically relevant, since a major portion of the acid extractable cyclic AMP may be biologically inert (see discussion by Larner ( 19)). These small decreases in CAMP concentration that were sometimes noted after insulin administration could conceivably influence the system on the basis of the compartmental concept referred to above. The present experiments support an action of insulin on some aspect of cyclic AMP metabolism, since insulin administered at the same time as glucagon (Table  1 , footnote) resulted in a much smaller rise in CAMP concentration than occurred when glucagon was given alone (Table  3) . However, the possibility still remains that other factors consequent to insulin administration may be more directly related to the changes in transferase I and phosphorylase activity when these are brought about under more physiological conditions (i.e., not in conjunction with large doses of glucagon). Furthermore, the relevance to insulin action of a change in cellular CAMP level has been questioned more recently by the experiments of Nichols and Goldberg (unpublished data), as quoted by . These investigators found, in the early periods following insulin administration to rats, that liver transferase I activity apparently increased minutes before a measurable decrease in liver CAMP concentration was detectable.
Alteration of Activity State of One of the Interconuerting Enzymes for Glycogen Transferase
Inactivation of transferase I kinase. These experiments did not test, but do not exclude, the possibility that in liver, as in muscle (32), insulin administration promotes the transformation of the kinase of transferase I to a less active state, as discussed in detail by Larner et al. ( 19) . This would constitute an action stemming directly from insulin itself on this interconverting enzyme of the transferase system. However, it appears (vide infra) that an activity of insulin can influence the other interconverting component (i.e., the phosphatase) of this system in liver, even though such an influence has not yet been apparent in muscle ( 19) .
Activation of transferase D phosfihatase. A 2-to 4-fold increase in the activity of transferase D phosphatase was observed during the infusion of insulin with glucose, when the activity of this enzyme was measured in some of the sample shown in Table 3 (1). Th e insulin dependence of the activation of phosphatase was apparent from the fact that phosphatase activation did not occur during comparable insulin-withglucose infusions in animals that were in the diabetic state not controlled with exogenous insulin for over 96 hr, even tholqh small increases in transferase I activity were observed in this condition (Table 4) . High cellular glucose concentration alone may sometimes result in transferase activation in the intact dog, as found by Glinsmann et al. ( 10) and others (6) in the isolated perfused rat liver. For instance, a twofold increase in transferase activity was observed during the 30-min glucose infusion in one experiment (Table 3 , experiment 6 C-1)). This partial activation of transferase was associated with the gradual development of an increase in the activity of transferase D phosphatase, which is reported elsewhere ( 1). Addition of insulin to the glucose infusion in the subsequent 30 min resulted in no further increase in phosphatase activity, but did result in further activation of transferase. From the sequence of the development of the changes in activity of these two enzymes in this experiment, it is clear that phosphatase activation alone is not sufficient for maximal transferase activation.
On the other hand, in two other experiments (Table 3 , experiment 7 (C-1) and Table 3 , dog 6 in ref. 1) no such activation of phosphatase (or transferase) was seen with glucose infusion until insulin was added. The mechanism of this occasional effect of glucose to promote an increase in the activity of transferase D phosphatase is not known.
In the diabetic pancreatectomized dog (Table 4) in which there was low activity of transferase D phosphatase (l), transferase was not activated by the high basal glucose concentration.
In this condition infused insulin produced only partial activation of transferase in 30-120 min. However, this activation of transferase is brought about without the associated activation of phosphatase which occurs in the normal. The mechanism of the activation of transferase in this condition (i.e., chronic insulin deprivation) is not known. On the other hand, it has been suggested elsewhere (1) that the sluggish activation of transferase during insulin infusion in the diabetic pancreatectomized dog represents a type of insulin resistance which may be due to the inability of the phosphatase to become rapidly activated, since no abnormal elevation of cyclic AMP concentration in the liver was observed.
In summary, it appears that activation of liver glycogen transferase by insulin (and in the presence of glucose) may operate through one mechanism or a combination of mechanisms, either individually or in concert. Further study will be required to understand the molecular events in this complex regulatory system. 
APPENDIX
